Germany - Events

Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle. From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma. Key Topics Include:  Transformative portfolio management approaches using AI Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution Bridging the Gap Between Market Objectives and Research Needs Achieving a strategic…

Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle. From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma. Key Topics Include:  Transformative portfolio management approaches using AI Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution Bridging the Gap Between Market Objectives and Research Needs Achieving a strategic…

mRNA is no longer just a headline, it's transforming medicine. From BioNTech's acquisition of CureVac to the EMA's and MHRA's latest guidance on mRNA product development, and even the world's first personalised CRISPR therapy for Baby KJ, the field has reached a new level of stability while opening doors to revolutionary therapeutic and gene editing applications. Returning for its fifth year, the mRNA-Based Therapeutics Summit Europe gives you the insights and connections to turn these breakthroughs into action. The new Gene Editing Focus Day highlights how mRNA enables safer, transient editing strategies, while addressing regulatory and translational challenges. Hear directly from Moderna, AstraZeneca, CybernaX Bio, Avocet Bio, and others about clinical readiness and delivery innovations…

The marcus evans S&OP and IBP for Pharma & Life Science conference taking place on 23-25 March, 2026, in Frankfurt, Germany, will bring together senior leaders in supply chain, finance, and planning to explore how pharmaceutical and life sciences organizations are transforming S&OP/IBP to accelerate decision-making, enhance planning accuracy, and strengthen business alignment. Key Topics Include:  Transform S&OP into IBP to Connect Strategy, Finance, and Execution Cross Functional Collaboration – Key for Successful S&OP/IBP Balance Short- and Long-Term Planning to Enable Strategic Alignment Leverage AI and Data to Strengthen S&OP and IBP Foundations Drive Change Management to Advance S&OP and IBP Maturity Align Portfolio and Demand to Build a Single Planni…